| Suicide prevention strategies revisited: 10-year systematic review G Zalsman, K Hawton, D Wasserman, K van Heeringen, E Arensman, ... The Lancet Psychiatry 3 (7), 646-659, 2016 | 1762 | 2016 |
| Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance O Király, MN Potenza, DJ Stein, DL King, DC Hodgins, JB Saunders, ... Comprehensive psychiatry 100, 152180, 2020 | 908 | 2020 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders … B Bandelow, J Zohar, E Hollander, S Kasper, HJ Moeller, ... The World Journal of Biological Psychiatry 9 (4), 248-312, 2008 | 747 | 2008 |
| Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study D Souery, P Oswald, I Massat, U Bailer, J Bollen, K Demyttenaere, ... Journal of Clinical Psychiatry 68 (7), 1062-1070, 2007 | 610 | 2007 |
| Treatment resistant depression: methodological overview and operational criteria D Souery, J Amsterdam, C De Montigny, Y Lecrubier, S Montgomery, ... European Neuropsychopharmacology 9 (1-2), 83-91, 1999 | 603 | 1999 |
| Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls J Zohar, EA Mueller, TR Insel, RC Zohar-Kadouch, DL Murphy Archives of General Psychiatry 44 (11), 946-951, 1987 | 527 | 1987 |
| Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology J Zohar, TR Insel Biological psychiatry 22 (6), 667-687, 1987 | 520 | 1987 |
| Treatment non-response in OCD: methodological issues and operational definitions S Pallanti, E Hollander, C Bienstock, L Koran, J Leckman, D Marazziti, ... International Journal of Neuropsychopharmacology 5 (2), 181-191, 2002 | 499 | 2002 |
| Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care B Bandelow, L Sher, R Bunevicius, E Hollander, S Kasper, J Zohar, ... International journal of psychiatry in clinical practice 16 (2), 77-84, 2012 | 484 | 2012 |
| Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. MT Pato, R Zohar-Kadouch, J Zohar, DL Murphy The American journal of psychiatry 145 (12), 1521-1525, 1988 | 424 | 1988 |
| Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment N Brunello, JRT Davidson, M Deahl, RC Kessler, J Mendlewicz, ... Neuropsychobiology 43 (3), 150-162, 2001 | 406 | 2001 |
| Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment J Zohar, TR Insel, RC Zohar-Kadouch, JL Hill, DL Murphy Archives of General Psychiatry 45 (2), 167-172, 1988 | 394 | 1988 |
| The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence D Denys, J Zohar, HG Westenberg J Clin Psychiatry 65 (Suppl 14), 11-17, 2004 | 380 | 2004 |
| Paroxetine versus clomipramine in the treatment of obsessive–compulsive disorder J Zohar, R Judge, OCD Paroxetine Study Investigators The British Journal of Psychiatry 169 (4), 468-474, 1996 | 373 | 1996 |
| Epidemiology of obsessive-compulsive disorder: a world view Y Sasson, J Zohar, M Chopra, M Lustig, I Iancu, T Hendler Journal of Clinical Psychiatry 58 (12), 7-10, 1997 | 362 | 1997 |
| High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies J Zohar, H Yahalom, N Kozlovsky, S Cwikel-Hamzany, MA Matar, ... European Neuropsychopharmacology 21 (11), 796-809, 2011 | 352 | 2011 |
| Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial L Carmi, A Tendler, A Bystritsky, E Hollander, DM Blumberger, ... American Journal of Psychiatry 176 (11), 931-938, 2019 | 323 | 2019 |
| Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats H Cohen, J Zohar, Y Gidron, MA Matar, D Belkind, U Loewenthal, ... Biological psychiatry 59 (12), 1208-1218, 2006 | 323 | 2006 |
| The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder H Cohen, T Liu, N Kozlovsky, Z Kaplan, J Zohar, AA Mathé Neuropsychopharmacology 37 (2), 350-363, 2012 | 318 | 2012 |
| The relevance of differential response to trauma in an animal model of posttraumatic stress disorder H Cohen, J Zohar, M Matar Biological psychiatry 53 (6), 463-473, 2003 | 312 | 2003 |
